Bank of America
FLNA

Bank of America’s Filana Therapeutics FLNA Stock Holding History

Bank of America’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-39,000
Closed -$113K – 8204
2025
Q3 		$113K Sell
39,000
-200
-0.5% -$460 ﹤0.01% 6546
2025
Q2 		$71K Buy
39,200
+33,900
+640% +$60.3K ﹤0.01% 6673
2025
Q1 		$7.95K Sell
5,300
-112,500
-96% -$284K ﹤0.01% 7154
2024
Q4 		$278K Buy
117,800
+12,500
+12% +$220K ﹤0.01% 5942
2024
Q3 		$3.1M Buy
105,300
+75,800
+257% +$1.75M ﹤0.01% 4188
2024
Q2 		$364K Buy
29,500
+15,000
+103% +$316K ﹤0.01% 5541
2024
Q1 		$294K Buy
+14,500
New +$334K ﹤0.01% 5672
2023
Q4 		– Sell
-5,000
Closed -$83.2K – 8200
2023
Q3 		$83.2K Buy
+5,000
New +$99.1K ﹤0.01% 6320
2023
Q1 		– Sell
-6,000
Closed -$177K – 8211
2022
Q4 		$177K Sell
6,000
-44,100
-88% -$1.58M ﹤0.01% 5976
2022
Q3 		$2.1M Buy
50,100
+35,100
+234% +$948K ﹤0.01% 4229
2022
Q2 		$422K Buy
+15,000
New +$379K ﹤0.01% 5553
2021
Q3 		– Sell
-117,800
Closed -$10.1M – 8353
2021
Q2 		$10.1M Buy
+117,800
New +$6.31M ﹤0.01% 2855

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Bank of America's FLNA Position: Q1 2026 in Review

Bank of America sold out of Filana Therapeutics (FLNA) in Q1 2026, closing a stake of 13,531 shares — an estimated $26.8K sold.

Bank of America first reported a position in FLNA in Q2 2013 and held it in 51 quarters. The position peaked at $12M in Q4 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Bank of America reported no remaining Filana Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 13,531 Filana Therapeutics shares in Q1 2026, an estimated $26.8K.
  • Bank of America first reported a position in Filana Therapeutics in Q2 2013 and held it in 51 quarters.
  • Bank of America's Filana Therapeutics position peaked at $12M in Q4 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.